AI Software Focus Delivers Paid Work While Infinite Auctions and Real Game Used Build Revenue Ahead of Q3 Results MESA,...
More Than 540 People with Diabetes Participated in a Three-Phase Study of Treatment Burden, Pump Adoption Barriers and Perceptions of...
In lab studies, APVO451 and APVO452 helped immune cells kill cancer cells despite conditions that suppress immune activity - offering...
Releaf becomes first UK medical cannabis clinic to offer THCV since 1973, for weight managementReleaf becomes the first medical cannabis...
Capital efficiency strategy prioritizes CD228V development while seeking separate public listing for SkinJect® and partners to advance Teverelix® PHILADELPHIA, PA...
Winter Park, Florida--(Newsfile Corp. - November 9, 2026) - Adia Med Inc. (OTCQB: ADIA) today released the following open letter...
NEW YORK, Nov. 9, 2026 /PRNewswire/ -- An AI tool can analyze patients' narratives about injuries that sent them to...
ZUG, Switzerland, November 9, 2026 -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on...
ZUG, Switzerland, November 9, 2026 -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on...
Comprehensive clinical and scientific data supporting Phase 2 development of nangibotide in ACLF unveiled to leading experts during AASLD The...
Partnership brings together decades of pancreatin experience at Nordmark and Essential PharmaNorzyme® (pancreas powder) 25,000 gastro-resistant capsules, a Nordmark medicine,...
Dapirolizumab pegol (DZP) associated with higher response rates using the novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): A...
SHANGHAI, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven...
Total Company Revenue increased 22.1% to $638.3 million in the third quarter of 2026 from $522.9 million in the third...
Single administration of CIDEBsiRNA resulted in rapid, deep and durable reductions in liver fat by up to 80% that were...
ALKIVIA met its primary and key secondary endpoints in the combined IMNM and DM populationFirst Phase 3 study to demonstrate...
READ BRIEFS HEREDuane Boise CEO MMJ International stated "As DEA Chief Administrative Law Judge Julius Weighs His Decision Amid Disturbing...
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and...
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology...
Investor Conference Call Scheduled for Thursday, November 12, 2026 at 8:30 a.m. EasternHALLANDALE BEACH, Fla., Nov. 6, 2026 /PRNewswire/ --...